Portfolio company
Orb Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops programmable RNA therapeutics and computational platforms to treat patients with genetic and neurological diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Orna Therapeutics
This company develops engineered circular RNA therapies and delivery systems to treat patients with cancer, autoimmune conditions, and genetic diseases.
Shape Therapeutics
The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.
Skyhawk Therapeutics
This company develops small molecules that modulate RNA for patients with rare neurological, oncological, and autoimmune diseases.
Typewriter Therapeutics
The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.
Crucible Therapeutics
This biotechnology company develops RNA-based therapies for patients with neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal dementia.
Tacit Therapeutics
This company develops RNA trans-splicing medicines to repair genetic mutations for patients with inherited neurological diseases and other complex gene-mediated conditions.
Ribonaut Therapeutics
Ribonaut Therapeutics develops small molecule drugs that target and degrade disease-causing RNA to treat neurological conditions and movement disorders for human patients.
Biorchestra
The company develops RNA-based medicines and delivery systems for patients with neurodegenerative and rare central nervous system diseases.